Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

Scott W. Biggins(Mount Sinai Medical Center), W. Ray Kim(University of California, San Francisco), Norah A. Terrault(Mayo Clinic), Sammy Saab(Mount Sinai Medical Center), V Balan(Mayo Clinic in Arizona), Thomas D. Schiano(Mount Sinai Medical Center), Joanne Benson(Mayo Clinic in Arizona), Terry M. Therneau(Mayo Clinic), Walter K. Kremers(Mayo Clinic in Arizona), Russell H. Wiesner(Mount Sinai Medical Center), Patrick S. Kamath(University of California, San Francisco), Göran Klintmalm(Mayo Clinic)
Gastroenterology
May 1, 2006
10.1053/j.gastro.2006.02.010
Cited by 772

Abstract

Related Papers

Modeling Survival Data: Extending the Cox Model
Terry M. Therneau, Patricia M. Grambsch|Statistics in the health sciences|2000|8.6k
A Model to Predict Survival in Patients With End–Stage Liver Disease
Patrick S. Kamath, Russell H. Wiesner, Michael Malinchoc et al.|Hepatology|2001|4.9k
The new liver allocation system: Moving toward evidence-based transplantation policy
Richard B. Freeman, Russell H. Wiesner, Ann Harper et al.|Liver Transplantation|2002|726
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
Douglas M. Heuman, Souheil G. Abou‐Assi, Adil Habib et al.|Hepatology|2004|484
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
Josep Llach, Pere Ginès, Vicente Arroyo et al.|Gastroenterology|1988|469